Volume 12, Number 6—June 2006
Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season
|Characteristic||No. (%), N = 17|
|Median age, y (range)||21 (3 mo–62 y)|
|Sex, male||8 (47)|
|Underlying disease†||5 (29)|
|MRSA risk factors‡||4 (24)|
|Documented influenza vaccination||1 (6)|
|Evidence of influenza infection|
|Rapid antigen test||10 (59)|
|Paired serology||2 (12)|
|Fluorescent antibody staining||2 (12)|
|Sore throat||6 (35)|
|Shortness of breath||5 (29)|
|Temperature >38°C||12/13 (92)|
|Hypotension (systolic blood pressure <90 mm Hg)||12/13 (93)|
|Normal or elevated leukocyte count† (>3,500/mm3)||12/16 (75)|
|Median leukocyte count (range)||16,500 mm3 (6,000–295,000)|
|Leukopenia (<3,500/mm3)||4/16 (25)|
|Thrombocytopenia (<150,000/mm3)||6/16 (38)|
|Radiologic documentation of pneumonia¶#|
|Multiple lobe involvement||4/16 (25)|
|Diffuse/patchy infiltrates||6/16 (38)|
*MRSA, methicillin-resistant S. aureus.
†One each of diabetes, multiple sclerosis, prune belly syndrome, cystic fibrosis, eczema.
‡Hospitalization, dialysis, surgery, or residence in a long-term care facility in the previous year; ever having an MRSA infection; and presence of percutaneous device or catheter at time of culture.
§One patient had influenza infection confirmed by all methods.
¶One patient died on arrival at the hospital. #Not mutually exclusive.
- Page created: January 04, 2012
- Page last updated: January 04, 2012
- Page last reviewed: January 04, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)